Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

Advanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patients with this disease present alterations in the MET gene that encodes a hepatocyte growth factor receptor. Mutations in this gene are implicated in disease progression and can also contribute to cancer drug resistance. While the association of MET mutations with the development of this kidney cancer subtype has been well described, the effect of specifically targeting this gene is unclear.

Severe obesity riskier for Swedish men than American men, suggests thesis

The fact that obesity is a major risk factor for disease and death is well known, as is the fact that obesity is more common in the United States than in Europe. On the other hand, a new thesis at Umeå University shows that obese Swedish men are at greater risk of dying prematurely than equally obese American men. For women, however, the risk picture of obesity is similar in the countries.